With a background in neuroscience, clinical development and business administration, Lisa Halbherr combines scientific expertise with extensive experience in the regulatory and pharmaceutical development of innovative therapies. At ZH3D, she supports research and clinical teams in navigating the regulatory pathway from early development through clinical trials to marketing authorisation.